Back to VANGUARD GROUP INC VANGUARD GROUP INC

GYREGYRE
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in GYRE THERAPEUTICS INC

VANGUARD GROUP INC holds 1.2M shares of GYRE (GYRE THERAPEUTICS INC), worth $8.5M as of 2025-Q4. The position was increased (+4.4% shares). GYRE represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$8.5M

Current Shares

1.2M

Total Value Change

+$4.2M

Total Shares Change

+861,418

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
1.2M
+4.4%
$8.5M0.0%$7.02
29
2025-Q3
Increased
1.2M
+0.1%
$8.6M0.0%$7.50
27
2025-Q2
Increased
1.1M
+4.8%
$8.5M0.0%$7.42
29
2025-Q1
Increased
1.1M
+240.0%
$8.5M0.0%$9.11
44
2024-Q4
Decreased
322,464
-5.2%
$3.9M0.0%$12.66
0
2024-Q3
New
340,171
-
$4.3M0.0%$12.76
37

Other major holders of GYRE: VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used